Active Chiropractic Limited Liability Company Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 439 Main St, Suite 104, Saco, ME 04072 Phone: 207-571-8028 Fax: 866-213-8207 |
Dr. Frederick William Heidrich, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 52 King St, Saco, ME 04072 Phone: 207-284-2059 |
Dr. Roland Joseph Chasse, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7 Hutchins St, Saco, ME 04072 Phone: 207-282-5233 Fax: 207-282-1395 |
Jordan A Garlock, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3 Eastview Pkwy Ste 3, Saco, ME 04072 Phone: 207-284-1800 Fax: 207-284-1802 |
Dr. Brent Thomas Reiche, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 439 Main St, Saco, ME 04072 Phone: 207-571-8028 Fax: 866-213-8207 |
Southern Maine Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3 Eastview Pkwy Ste 3, Saco, ME 04072 Phone: 207-284-1800 Fax: 207-284-1802 |
David W. Benham, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 575 Main St, Saco, ME 04072 Phone: 207-283-0232 Fax: 207-286-8643 |
News Archive
Cellular Dynamics International, the world's largest producer of human tissue cells for drug discovery and safety testing, today announced the publication of research demonstrating an efficient and scalable method of creating DNA integration-free, or footprint-free, induced pluripotent stem cells under a feeder-free condition using chemically defined media.
Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
In an effort to meet the rising rates of melanoma head-on, The Wistar Institute today announced the creation of The Wistar Institute Melanoma Research Center. The Center brings together scientists, physicians, the life sciences industry, and melanoma advocates in saving lives by advancing new and better therapies for this deadly disease.
Bio-Techne Corporation announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million.
Research from scientists in Sweden has found that drinking alcohol halves the risk of developing rheumatoid arthritis.
› Verified 9 days ago